Guidance

Antimicrobial resistance: develop solutions in the UK

Overview of the UK's antimicrobial resistance (AMR) research infrastructure and advantages of investment in the UK's life science sector to support new treatments.

• From: Life Sciences Organisation and Department for International Trade
• Published: 15 October 2018

Documents

Antimicrobial resistance: develop solutions in the UK

HTML

Details

A summary of the UK’s strengths as centre for AMR, including:

• reasons to select the UK as a partner for development
• information on infrastructure for treatment, diagnostics and systems research and development
• information on risk reduction and efficient routes to product development

Published 15 October 2018